Literature DB >> 10689778

Macrophage activation by immunostimulatory DNA.

K J Stacey1, D P Sester, M J Sweet, D A Hume.   

Abstract

Macrophage/dendritic cells and B cells remain the only cell types where direct responses to CpG DNA are well established. The role of macrophages in vivo in DNA clearance and the potent cytokine induction in macrophages and dendritic cells places them in the central role in the in vivo response to foreign DNA. Although responses to DNA are unlikely to evolve and be retained if they are not significant in the immune response to infection, the relative contributions of DNA and other stimulators of the innate immune recognition of foreign organisms is difficult to assess. Although CpG DNA and LPS have similar actions, significant differences are emerging that make the use of DNA as a therapeutic immunostimulatory molecule feasible. The macrophage response to DNA generates cytokines favouring the development of Th1-type immunity, and active oligonucleotides now show promise as Th1-promoting adjuvants and as allergy treatments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689778     DOI: 10.1007/978-3-642-59672-8_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  6 in total

1.  Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Rescuing macrophage function following severe thermal injury.

Authors:  Jeremy L Herrmann
Journal:  J Surg Res       Date:  2009-05-14       Impact factor: 2.192

3.  CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.).

Authors:  Jorunn B Jørgensen; Lill-Heidi Johansen; Kari Steiro; Audny Johansen
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells.

Authors:  Astrid Friebe; Angela Siegling; Sonja Friederichs; Hans-Dieter Volk; Olaf Weber
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.

Authors:  X P Ioannou; P Griebel; R Hecker; L A Babiuk; S van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 6.  The dichotomy of pathogens and allergens in vaccination approaches.

Authors:  Fiona J Baird; Andreas L Lopata
Journal:  Front Microbiol       Date:  2014-07-16       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.